site stats

Immunic investor relations

Witryna8 mar 2024 · Archived Events. Date. Event Details. Mar 8, 2024 10:30 AM EST. 43rd Annual Cowen Health Care Conference. Listen to webcast. Feb 6, 2024 4:30 PM EST. Arrowhead Pharmaceuticals 2024 First Quarter Results. Listen to webcast. Witryna6 lip 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ...

Investor Relations Center - Handelsblatt Online

Witryna6 lis 2024 · Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q3 2024 Earnings Conference Call November 3, 2024 8:00 AM ETCompany ParticipantsJessica Breu - Head, IR and CommunicationsDaniel Vitt - CEO and... Witryna23 sie 2024 · Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. ... Head of Investor Relations and Communications. Standort. Größere Karte. Gräfelfing. Lochhamer Schlag 21, 82166 … ifly2fsuipc https://bridgetrichardson.com

Pfizer Inc. - Investor Relations - Events & Presentations

Witryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … Witryna31 gru 2024 · Results of Operations. The Company reported a net loss of $41.5 million for the year ended December 31, 2024, which compared with a net loss of $52.1 million for the prior year. This resulted in a net loss of $0.98 per share for the year ended December 31, 2024, as compared to a net loss of $1.31 per share for 2024, on both a … Witryna2 dni temu · Telenor ASA appointed Frank Maao as senior vice president for capital markets and investor relations, according to a statement. Maao comes from the … is sssniperwolf alive 2022

Jessica Breu - Head of Investor Relations and …

Category:Immunic gets a "positive surprise" from lead asset trial

Tags:Immunic investor relations

Immunic investor relations

Press Releases Travere Therapeutics, Inc.

Witryna15 lip 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Or. Rx Communications … Witryna28 wrz 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 322 2216 [email protected]

Immunic investor relations

Did you know?

Witryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE … Witryna14 lip 2024 · NEW YORK, July 14, 2024 /PRNewswire/ -- Immunic, Inc. (the "Company") (Nasdaq: IMUX ), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies ...

Witryna5 kwi 2024 · Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and … Witryna23 lut 2024 · /PRNewswire/ -- Immunic, Inc. (NASDAQ: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx …

Witryna14 mar 2024 · Seed-Investment des HTGF: Münchner Startup oculai schließt 2,5 Mio. € Seed-Runde zur KI-gestützten Prozesserfassung auf Baustellen ab ... Parcellab, Cobrainer, Quantum Systems, Casavi, Riskmethods, Tubulis, Catalym, Immunic, Sirion und viele weitere. ... Stefanie Grüter, Partner Communications & Relations T.: +49 … Witryna17 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Melody Carey +1 917 322 2571 [email protected]. US Media Contact KOGS Communication Edna Kaplan +1 781 639 1910 [email protected]

WitrynaImmunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune …

Witryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected] is sssniperwolf sisters with azzylandWitryna22 lut 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 [email protected] ifly 4 softwareWitryna14 kwi 2024 · Immunic Inc. (NASDAQ: IMUX)’s stock price has soared by 10.14 in relation to previous closing price of 1.38. Nevertheless, the company has seen a loss of -1.94% in its stock price over the last five trading days. According a new report published by BloombergNEF on investment in the energy ... ifly50.comWitryna26 lut 2024 · /PRNewswire/ -- Immunic, Inc. (Nasdaq: ... Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … ifly 360ifly 28 hard-sided luggage racerhttp://www.neurobopharma.com/ ifly 02Witryna5 kwi 2024 · Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune … Investor Relations. IR Home; News Releases; Events and Presentations; Stock … Webcasts and presentations that have been archived are available by viewing hi… 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 3… Immunic Therapeutics Jessica Breu Head of Investor Relations and Communic… Immunic is privately held and supported by several renowned healthcare invest… ifly529